Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
DARMSTADT, Germany, Sept. 11, 2015 /CNW/ - ECC Abstract #: Avelumab*: 3090, 2749, 2364, 2630, 3110, 2398; Erbitux: 2120, 2112, 420, 2400, 2820; evofosfamide: 2312; tepotinib: 365, 2353, 3082, 369....
DARMSTADT, Germany, June 30, 2015 /CNW/ - Not intended for US based media Merck Serono continues to provide health care professionals with innovative fertility technologies that aim to improve embryo ...
Not intended for US based media - Global Fertility Alliance will identify and work on improvements of fertility-related laboratory processes DARMSTADT, Germany, June 8, 2015 /CNW/ - Merck, a leading...
- Global collaboration to extend the portfolio of Merck Serono, a leading company in fertility treatment, in the growing market of fertility technologies to support standardization and improve...
Hypothyroidism is a disease affecting millions which often goes unrecognized Symptoms of hypothyroidism often mistaken for other diseases DARMSTADT, Germany, May 26, 2015 /CNW/ - Merck Serono, the...
CHMP recommendation based on results from the Phase IIIb SPARK study /NOT INTENDED FOR UK BASED MEDIA/ DARMSTADT, Germany, May 22, 2015 /CNW/ - Merck Serono, the biopharmaceutical business of Merck,...
DARMSTADT, Germany and BARCELONA, Spain, Feb. 20, 2015 /CNW/ - Vall d'Hebron, Spain: first hospital to use liquid biopsy RAS biomarker testing technology Leading research center will use technology...
- MSdialog designed to provide people with multiple sclerosis (MS) and health care providers with injection history, treatment adherence information and health reports - RebiSmart injection device...
Merck Serono, a division of Merck KGaA, Darmstadt, Germany (operates as EMD Serono in Canada) will receive commercialization rights from Auxogyn for the Eeva Test, which is designed to provide...
The multidisciplinary Oncology Partnership and Education Network (OPEN) aims to improve patient outcomes in oncology, with initial focus on metastatic colorectal cancer (mCRC) OPEN aims to raise...
Publication offers detailed results of START, including an exploratory analysis of the clinically meaningful survival prolongation with tecemotide maintenance therapy in a predefined subgroup of...
GENEVA, Jan. 21 /CNW/ - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the online publication of the results from the CLARITY(1) Phase III trial using Cladribine Tablets...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.